ArticleBritish journal of pharmacology2013

Increasing doxorubicin activity against breast cancer cells using PPARγ-ligands and by exploiting circadian rhythms.

I S Arif et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.